搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Staphylococcus aureus Lactonase drp35 (drp35) CSB-YP847807SUL
CSB-EP847807SUL
CSB-BP847807SUL
CSB-MP847807SUL
CSB-EP847807SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP847808SUL
CSB-EP847808SUL
CSB-BP847808SUL
CSB-MP847808SUL
CSB-EP847808SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Ornithine carbamoyltransferase, catabolic (arcB) CSB-YP847809SUL
CSB-EP847809SUL
CSB-BP847809SUL
CSB-MP847809SUL
CSB-EP847809SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Diapolycopene oxygenase (crtP) CSB-YP847810SUL
CSB-EP847810SUL
CSB-BP847810SUL
CSB-MP847810SUL
CSB-EP847810SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus PTS system glucoside-specific EIICBA component (glcB), partial CSB-YP847811SUL
CSB-EP847811SUL
CSB-BP847811SUL
CSB-MP847811SUL
CSB-EP847811SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Isopentenyl-diphosphate delta-isomerase (fni) CSB-YP847812SUL
CSB-EP847812SUL
CSB-BP847812SUL
CSB-MP847812SUL
CSB-EP847812SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Molybdopterin synthase catalytic subunit (moaE) CSB-YP847813SUL
CSB-EP847813SUL
CSB-BP847813SUL
CSB-MP847813SUL
CSB-EP847813SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Arginase (arg) CSB-YP847814SUL
CSB-EP847814SUL
CSB-BP847814SUL
CSB-MP847814SUL
CSB-EP847814SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0340 protein MW2038 (MW2038) CSB-YP847815SUL
CSB-EP847815SUL
CSB-BP847815SUL
CSB-MP847815SUL
CSB-EP847815SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP847816SUL
CSB-EP847816SUL
CSB-BP847816SUL
CSB-MP847816SUL
CSB-EP847816SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Staphylokinase (sak) CSB-YP847817SUL
CSB-EP847817SUL
CSB-BP847817SUL
CSB-MP847817SUL
CSB-EP847817SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Regulatory protein recX (recX) CSB-YP847818SUL
CSB-EP847818SUL
CSB-BP847818SUL
CSB-MP847818SUL
CSB-EP847818SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 2-succinylbenzoate--CoA ligase (menE) CSB-YP847819SUL
CSB-EP847819SUL
CSB-BP847819SUL
CSB-MP847819SUL
CSB-EP847819SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Arsenical pump membrane protein (arsB), partial CSB-YP847820SUL
CSB-EP847820SUL
CSB-BP847820SUL
CSB-MP847820SUL
CSB-EP847820SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Acetoin utilization protein AcuC (acuC) CSB-YP847821SUL
CSB-EP847821SUL
CSB-BP847821SUL
CSB-MP847821SUL
CSB-EP847821SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable thiol peroxidase (tpx) CSB-YP847822SUL
CSB-EP847822SUL
CSB-BP847822SUL
CSB-MP847822SUL
CSB-EP847822SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP847823SUL
CSB-EP847823SUL
CSB-BP847823SUL
CSB-MP847823SUL
CSB-EP847823SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Heat-inducible transcription repressor HrcA (hrcA) CSB-YP847824SUL
CSB-EP847824SUL
CSB-BP847824SUL
CSB-MP847824SUL
CSB-EP847824SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Segregation and condensation protein B (scpB) CSB-YP847825SUL
CSB-EP847825SUL
CSB-BP847825SUL
CSB-MP847825SUL
CSB-EP847825SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Nucleoside diphosphate kinase (ndk) CSB-YP847826SUL
CSB-EP847826SUL
CSB-BP847826SUL
CSB-MP847826SUL
CSB-EP847826SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>